(C) CQ402 What should we tell the patient when prescribing oral contraceptives (OC)? Answer Provide information based on the ‘Guidelines concerning the use of low-dose oral contraceptives (year 2007 revision)’. 1 Efficacy and safety: OC is the most effective reversible method of contraception available. It is also very safe. (B) CQ403 What should we inform the patient when an intrauterine device (IUD) (including the intrauterine system) is chosen for contraception? Answer Provide information as below.

1 It does not prevent pregnancy without fail. (A) CQ404 How do we manage Turner’s syndrome? Answer 1 For patients diagnosed before puberty, growth hormone may be needed for treatment. Management of patient can be carried out in coordination with a pediatrician/endocrinologist. (A) CQ405 How should we provide care for XY female patients? Answer 1 After definitive diagnosis is made, provide appropriate Fer-1 chemical structure counseling mTOR inhibitor for both the patient and her parents. (B) CQ406 How do we provide care for patients with Mayer–Rokitansky–Küster (–Hauser) syndrome? Answer 1 Provide information for the patient regarding her medical condition in

a timely and approachable manner. (A) CQ407 What are the important points when we perform medical examinations on an adolescent? Answer 1 Medical interviews are very important, and can be conducted with or without the accompaniment of a family member. (B) CQ408 What are the important points when treating a female adolescent? Answer 1 For amenorrhea, use cyclic progestins therapy or cyclic estrogen–progestin therapy once every 2–3 months. (C) CQ409 What should we do when we encounter a sexual assault

victim? Answer 1 Victims who have not reported their ordeal to the law enforcement authorities should be reported to the police after obtaining their consent before any medical examination takes place. (A) CQ410 How do we help patients modify their menstrual cycle? Answer 1 To shorten the menstrual cycle, administer combined estrogen–progestin (EP) or norethisterone from the 3rd to 7th day of the menstrual cycle for 10–14 days. (B) CQ411 What are the important points in the diagnosis of NADPH-cytochrome-c2 reductase climacteric disorder? Answer 1 Suspect climacteric disorder in a woman who has already undergone menopause that comes with a myriad of complaints. (A) CQ412 How should we treat climacteric disorder? Answer 1 Hormone replacement therapy is effective for symptoms caused by autonomous nervous system dysregulation, such as flushing, sweating, insomnia etc. (B) CQ413 How should we provide information regarding the side-effects of hormone replacement therapy and the corresponding strategies for treatment? Answer 1 The minor side-effects are: (A) Abnormal vaginal bleeding, mastalgia (breast pain), breast swelling. Breast cancer, ovarian cancer, lung cancer, coronary vascular disease, ischemic cerebral stroke, thromboembolism.